Drug Profile
Deudomperidone - CinRx Pharma
Alternative Names: CIN-102; Deuterated domperidone; Domperidone deuterated - CinRx PharmaLatest Information Update: 15 May 2023
Price :
$50
*
At a glance
- Originator CinRx Pharma
- Developer CinDome Pharma
- Class Antiemetics; Benzimidazoles; Chlorinated hydrocarbons; Gastrokinetics; Organic deuterium compounds; Piperidines; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Gastroparesis
Most Recent Events
- 08 May 2023 Efficacy data from the phase I trial in Healthy volunteers presented at the Digestive Disease Week 2023 (DDW-2023)
- 27 Mar 2023 CinDome Pharma initiates phase II envision3D trial for Diabetic gastroparesis in the USA (NCT05832151)
- 26 Jul 2022 NCT04026997/700309648 - NDR: incorporated QC feedback